QA: Filana Therapeutics INC in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001069530_2018_Filana_Therapeutics_INC.pdf

Logs

Graph

Absolute values for 0001069530, Filana Therapeutics INC

  xvar xval
0 AssetsCurrent 10,663,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 156,000
3 remainder_Assets 12,000
4 LiabilitiesCurrent 1,132,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,322,009
9 ResearchAndDevelopmentExpense 7,717,613
10 remainder_Expenses 0
11 remainder_Revenues 60,370
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 10,831,000
1 Liabilities 1,132,000
2 Expenses 12,039,622
3 Revenues 60,370
4 StockholdersEquity 9,699,000
5 NetIncome -11,979,252
6 ComprehensiveNetIncome -11,979,252
7 BaseVar 12,031,496
8 EconomicCapitalRatiobeforeLimitedLiability 1.53
9 EconomicCapitalRatio 2.70

Edgar->Model Mapping

Feature Distribution

Change over Time